BioCentury | May 5, 2016
Distillery Therapeutics

Therapeutics: β-catenin (CTNNB1); wingless-type MMTV integration site family member 3A (WNT3A); 7-dehydrocholesterol reductase (DHCR7); glycogen synthase kinase

...CTNNB1 signaling could help treat microcephaly associated with Smith-Lemli-Opitz syndrome, a developmental disorder caused by DHCR7...
...cells from patients. TARGET/MARKER/PATHWAY: β-catenin (CTNNB1); wingless-type MMTV integration site family member 3A (WNT3A) ; 7-dehydrocholesterol reductase (DHCR7)...
Items per page:
1 - 1 of 1